Fig. 2From: Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatinOverall survival (OS) and progression-free survival (PFS) of patients treated with gemcitabine plus cisplatinBack to article page